Killer cell immunoglobulin-like receptors in Thai patients with multiple myeloma
dc.contributor.author | Theeranawakam A. | |
dc.contributor.author | Vejbaesya S. | |
dc.contributor.author | Khuhapinant A. | |
dc.contributor.author | Sae-Tam P. | |
dc.contributor.correspondence | Theeranawakam A. | |
dc.contributor.other | Mahidol University | |
dc.date.accessioned | 2024-04-05T18:07:22Z | |
dc.date.available | 2024-04-05T18:07:22Z | |
dc.date.issued | 2024-03-01 | |
dc.description.abstract | BACKGROUND: Natural killer (NK) cells have been implicated in the immune response against multiple myeloma (MM) cells. Killer cell immunoglobulin-like receptors (KIRs) regulate NK cell activity by recognizing specific human leukocyte antigen (HLA) class I as ligands. OBJECTIVE: To investigate the association of KIR genes and ligands with MM in the Thai population. METHODS: KIR gene polymorphisms and their HLA ligands were investigated in 66 Thai patients with MM and 200 healthy controls. RESULTS: The frequencies of KIR3DL1 and 2DS4 were significantly lower in myeloma patients than in controls (P = 0.02). The frequencies of KIR3DL1, 2DS4, 2DL1 with C2, and 3DL1 with Bw4 were significantly higher in the patients achieving > very good partial response (VGPR) than those achieving ≤ VGPR after treatment with bortezomib (P = 0.009, 0.009, 0.01, and 0.02, respectively). CONCLUSIONS: This study suggests the association of KIR genes with the protection against MM and the association of inhibitory KIR and ligands with the response to treatment in MM. | |
dc.identifier.citation | Asian Pacific journal of allergy and immunology Vol.42 No.1 (2024) , 77-80 | |
dc.identifier.doi | 10.12932/AP-130520-0842 | |
dc.identifier.issn | 0125877X | |
dc.identifier.pmid | 33386786 | |
dc.identifier.scopus | 2-s2.0-85152083171 | |
dc.identifier.uri | https://repository.li.mahidol.ac.th/handle/20.500.14594/97872 | |
dc.rights.holder | SCOPUS | |
dc.subject | Medicine | |
dc.title | Killer cell immunoglobulin-like receptors in Thai patients with multiple myeloma | |
dc.type | Article | |
mu.datasource.scopus | https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85152083171&origin=inward | |
oaire.citation.endPage | 80 | |
oaire.citation.issue | 1 | |
oaire.citation.startPage | 77 | |
oaire.citation.title | Asian Pacific journal of allergy and immunology | |
oaire.citation.volume | 42 | |
oairecerif.author.affiliation | Siriraj Hospital |